Gossamer Bio, Inc. (GOSS)

CIK 1728117 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Gossamer Bio, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 20268-K0001728117-26-000094
Sep 9, 20268-K0001728117-26-000091
Sep 4, 2026D0001728117-26-000088
Sep 3, 2026PRE 14A0001728117-26-000086
Sep 3, 20268-K0001728117-26-000085
Aug 26, 202640001740847-26-000006
Aug 26, 20268-K0001728117-26-000079
Aug 26, 202640001553179-26-000005
Aug 26, 202640001857256-26-000006
Aug 26, 202640002003059-26-000008
Aug 26, 202640001352620-26-000006
Aug 24, 2026SCHEDULE 13D/A0001104659-26-100440
Aug 21, 20268-K0001728117-26-000077
Aug 13, 202610-Q0001728117-26-000072
Aug 13, 20268-K0001728117-26-000073
Jul 29, 2026SCHEDULE 13G/A0002012383-26-002802
Jul 29, 2026SCHEDULE 13G0001493152-26-035186
Jul 27, 20268-K0001728117-26-000064
Jul 24, 2026SCHEDULE 13D/A0001104659-26-086735
Jul 15, 20268-K0001728117-26-000061
Jul 1, 20268-K0001728117-26-000057
Jul 1, 2026SCHEDULE 13D/A0001104659-26-080004
Jun 17, 20268-K0001728117-26-000054
Jun 11, 2026SCHEDULE 13D0001104659-26-073089
Jun 11, 2026SCHEDULE 13G0001404574-26-000021